Latest Articles
Nivolumab Produces 68% Clinical CR Rate in Resectable dMMR Endometrial Cancer - OncLive
Nivolumab Produces 68% Clinical CR Rate in Resectable dMMR Endometrial Cancer OncLive
Published: June 19, 2026, 5:49 p.m.
Puxitatug Samrotecan Hits 60% Response Rate in Platinum- and IO-Pretreated Endometrial Cancer - Targeted Oncology
Puxitatug Samrotecan Hits 60% Response Rate in Platinum- and IO-Pretreated Endometrial Cancer Targeted Oncology
Published: June 19, 2026, 5:05 p.m.
Quick optical biopsy could be early detection method for endometrial cancer - Medical Xpress
Quick optical biopsy could be early detection method for endometrial cancer Medical Xpress
Published: June 19, 2026, 3:40 p.m.
Fertility-Preserving Therapy May Impair Endometrial Function and IVF Success After Endometrial Cancer:... - Medical Dialogues
Fertility-Preserving Therapy May Impair Endometrial Function and IVF Success After Endometrial Cancer:... Medical Dialogues
Published: June 19, 2026, 2:30 p.m.
Palbociclib Plus Anastrozole Is Safe and Effective in ER+ Recurrent Endometrial Cancer - OncLive
Palbociclib Plus Anastrozole Is Safe and Effective in ER+ Recurrent Endometrial Cancer OncLive
Published: June 19, 2026, 1:08 p.m.
Exploring Women's Experiences of Information Across Their Endometrial Cancer Diagnosis and Treatment - Docwire News
Exploring Women's Experiences of Information Across Their Endometrial Cancer Diagnosis and Treatment Docwire News
Published: June 19, 2026, 10:17 a.m.
AI imaging technique detects early endometrial cancer with high accuracy - News-Medical
AI imaging technique detects early endometrial cancer with high accuracy News-Medical
Published: June 19, 2026, 2:55 a.m.
Quick Optical Biopsy Could Be Early Detection Method for Endometrial Cancer | Newswise - Newswise
Quick Optical Biopsy Could Be Early Detection Method for Endometrial Cancer | Newswise Newswise
Published: June 18, 2026, 11:20 p.m.
Quick optical biopsy could be early detection method for endometrial cancer | Newswise - Newswise
Quick optical biopsy could be early detection method for endometrial cancer | Newswise Newswise
Published: June 18, 2026, 8:15 p.m.
Immunotherapy in dMMR/MSI-H endometrial cancer – a true game-changer? - ESMO Daily Reporter
Immunotherapy in dMMR/MSI-H endometrial cancer – a true game-changer? ESMO Daily Reporter
Published: June 18, 2026, 2:24 p.m.
Link copied to clipboard!